ClinicalTrials.gov
ClinicalTrials.gov Menu

Insertion Distance of Interscalene Perineural Catheters in the Context of Shoulder Surgery.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00754026
Recruitment Status : Completed
First Posted : September 17, 2008
Last Update Posted : May 28, 2010
Sponsor:
Information provided by:
Centre hospitalier de l'Université de Montréal (CHUM)

Brief Summary:
This study is designed to compare interscalene catheter insertion distances, in order to determine which is the best for pain relief after shoulder surgery.

Condition or disease Intervention/treatment Phase
Pain Procedure: Insertion of interscalene catheter for shoulder surgery Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Influence of the Insertion Distance on Loss of Sensation Produced by Interscalene Perineural Catheters in the Context of Shoulder Surgery.
Study Start Date : September 2008
Actual Primary Completion Date : May 2010
Actual Study Completion Date : May 2010

Arm Intervention/treatment
Active Comparator: 1 Procedure: Insertion of interscalene catheter for shoulder surgery
Distance of interscalene catheter: 2cm
Active Comparator: 2 Procedure: Insertion of interscalene catheter for shoulder surgery
Distance of interscalene catheter: 6cm



Primary Outcome Measures :
  1. Sensory block assessment [ Time Frame: 24 hours after surgery ]

Secondary Outcome Measures :
  1. Quality of pain relief [ Time Frame: 24 hours after surgery ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients aged 18 years and older undergoing elective shoulder surgery

Exclusion Criteria:

  • Severe COPD
  • Coagulopathy
  • Allergy to local anesthetics
  • Chronic use of opioids
  • Peripheral neuropathy of the operated limb
  • Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00754026


Locations
Canada, Quebec
Centre Hospitalier de l'Université de Montréal (Hôpital Notre-Dame)
Montreal, Quebec, Canada, H2L 4M1
Sponsors and Collaborators
Centre hospitalier de l'Université de Montréal (CHUM)
Investigators
Principal Investigator: Geneviève Arcand, MD, FRCPC Centre hospitalier de l'Université de Montréal (CHUM)

Responsible Party: Dr Geneviève Arcand, Centre Hospitalier de l'Université de Montréal
ClinicalTrials.gov Identifier: NCT00754026     History of Changes
Other Study ID Numbers: 08.072
First Posted: September 17, 2008    Key Record Dates
Last Update Posted: May 28, 2010
Last Verified: May 2010

Keywords provided by Centre hospitalier de l'Université de Montréal (CHUM):
Shoulder surgery